Cargando…

Objective assessment of compliance and persistence among patients treated for glaucoma and ocular hypertension: a systematic review

PURPOSE: This study summarizes findings from objective assessments of compliance (or adherence) and persistence with ocular hypotensive agents in patients with glaucoma and ocular hypertension. DESIGN: Systematic literature review. METHODS: A PubMed and reference list search was conducted across pub...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reardon, Gregory, Kotak, Sameer, Schwartz, Gail F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2011
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3191921/ https://www.ncbi.nlm.nih.gov/pubmed/22003282 http://dx.doi.org/10.2147/PPA.S23780

Ejemplares similares

Persistence on prostaglandin ocular hypotensive therapy: an assessment using medication possession and days covered on therapy
por: Reardon, Gregory, et al.
Publicado: (2010)

Incidence of new coding for dry eye and ocular infection in open-angle glaucoma and ocular hypertension patients treated with prostaglandin analogs: Retrospective analysis of three medical/pharmacy claims databases
por: Schwartz, Gail F, et al.
Publicado: (2011)

Development of ocular hypertension and persistent glaucoma after intravitreal injection of triamcinolone
por: Kocabora, M Selim, et al.
Publicado: (2008)

A multicenter, retrospective chart review study comparing index therapy change rates in open-angle glaucoma or ocular hypertension patients newly treated with latanoprost or travoprost-Z monotherapy
por: Fain, Joel M, et al.
Publicado: (2011)

Ocular surface disease in patients with glaucoma or ocular hypertension treated with either BAK-preserved latanoprost or BAK-free travoprost
por: Katz, Gregory, et al.
Publicado: (2010)

Brimonidine in the treatment of glaucoma and ocular hypertension
por: Cantor, Louis B
Publicado: (2006)

Topical Medication Therapy for Glaucoma and Ocular Hypertension
por: Wang, Tao, et al.
Publicado: (2021)

Corneal hysteresis in patients with glaucoma-like optic discs, ocular hypertension and glaucoma
por: Murphy, Melissa L., et al.
Publicado: (2017)

Travoprost in the management of open-angle glaucoma and ocular hypertension
por: Denis, Philippe, et al.
Publicado: (2007)

A Novel Indentation Assessment to Measure Corneal Biomechanical Properties in Glaucoma and Ocular Hypertension
por: Xu, Yunzhi, et al.
Publicado: (2021)

Pattern Electroretinogram in Ocular Hypertension, Glaucoma Suspect and Early Manifest Glaucoma Eyes: A Systematic Review and Meta-analysis
por: Gallo Afflitto, Gabriele, et al.
Publicado: (2023)

Correlation between ocular perfusion pressure and ocular pulse amplitude in glaucoma, ocular hypertension, and normal eyes
por: Figueiredo, Bruno P, et al.
Publicado: (2013)

Differential activity and clinical utility of latanoprost in glaucoma and ocular hypertension
por: Pacella, Fernanda, et al.
Publicado: (2012)

Clinical effectiveness of brinzolamide 1%–brimonidine 0.2% fixed combination for primary open-angle glaucoma and ocular hypertension
por: Sharma, Sourabh, et al.
Publicado: (2015)

Compliance and adherence in glaucoma management
por: Robin, Alan, et al.
Publicado: (2011)

Using CRISPR Interference as a Therapeutic Approach to Treat TGFβ2-Induced Ocular Hypertension and Glaucoma
por: Rayana, Naga Pradeep, et al.
Publicado: (2021)

Tafluprost for the Reduction of Interocular Pressure in Open Angle Glaucoma and Ocular Hypertension
por: Schultz, Clyde
Publicado: (2011)

Pharmacoeconomic analysis of prostaglandin and prostamide therapy for patients with glaucoma or ocular hypertension
por: Frenkel, Ronald EP, et al.
Publicado: (2007)

Clinical efficacy and neuroprotective effects of brimonidine in the management of glaucoma and ocular hypertension
por: Galanopoulos, Anna, et al.
Publicado: (2009)

Preservative-free tafluprost in the treatment of naive patients with glaucoma and ocular hypertension
por: Lanzl, Ines, et al.
Publicado: (2013)

The Latest Drugs in Development That Reduce Intraocular Pressure in Ocular Hypertension and Glaucoma
por: Jayanetti, Viran, et al.
Publicado: (2020)

Glucocorticoid Receptor Transactivation Is Required for Glucocorticoid-Induced Ocular Hypertension and Glaucoma
por: Patel, Gaurang C., et al.
Publicado: (2019)

Pars Plana Vitrectomy and the Risk of Ocular Hypertension and Glaucoma: Where Are We?
por: Rossi, Tommaso, et al.
Publicado: (2020)

Efficacy and Patient Tolerability of Omidenepag Isopropyl in the Treatment of Glaucoma and Ocular Hypertension
por: Matsuo, Masato, et al.
Publicado: (2022)

Decision Factors for Glaucoma Suspects and Ocular Hypertensive Treatment at an Academic Center
por: Ciociola, Elizabeth C, et al.
Publicado: (2023)

The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review
por: Cramer, J A, et al.
Publicado: (2008)

Ocular Biomechanics and Glaucoma
por: Brazuna, Rodrigo, et al.
Publicado: (2023)

Medical management of primary open-angle glaucoma: Best practices associated with enhanced patient compliance and persistency
por: Kulkarni, Sadhana V, et al.
Publicado: (2008)

Relationships between central corneal thickness and optic disc topography in eyes with glaucoma, suspicion of glaucoma, or ocular hypertension
por: Gunvant, Pinakin, et al.
Publicado: (2008)

Comparison of Newly Diagnosed Ocular Hypertension and Open-Angle Glaucoma: Ocular Variables, Risk Factors, and Disease Severity
por: Buys, Yvonne M., et al.
Publicado: (2012)

Efficacy, safety and tolerability of combination therapy with timolol and dorzolamide in glaucoma and ocular hypertension
por: Ichhpujani, Parul, et al.
Publicado: (2010)

Iris and periocular adverse reactions to bimatoprost in Japanese patients with glaucoma or ocular hypertension
por: Inoue, Kenji, et al.
Publicado: (2012)

Combination of brinzolamide and brimonidine for glaucoma and ocular hypertension: critical appraisal and patient focus
por: Nguyen, Quang H
Publicado: (2014)

Early Macular Angiography among Patients with Glaucoma, Ocular Hypertension, and Normal Subjects
por: Chao, Shih-Chun, et al.
Publicado: (2019)

Comparison of Lamina Cribrosa Morphology in Eyes with Ocular Hypertension and Normal-Tension Glaucoma
por: Kim, Ji-Ah, et al.
Publicado: (2020)

Comparative analysis of tear cytokines in patients with glaucoma, ocular hypertension, and healthy controls
por: Mravec Bencurova, Dominika, et al.
Publicado: (2023)

Impact of Inhaled and Intranasal Corticosteroids Exposure on the Risk of Ocular Hypertension and Glaucoma: A Systematic Review and Meta-Analysis
por: Vinokurtseva, Anastasiya, et al.
Publicado: (2022)

Corneal Biomechanics for Ocular Hypertension, Primary Open-Angle Glaucoma, and Amyloidotic Glaucoma: A Comparative Study by Corvis ST
por: Silva, Nisa, et al.
Publicado: (2022)

Current Imaging Modalities for assessing Ocular Blood Flow in Glaucoma
por: Mohindroo, Chirayu, et al.
Publicado: (2016)

Ocular perfusion pressure and ocular blood flow in glaucoma
por: Cherecheanu, A Popa, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_gruegnsuidodb47ulq3q9uh0jl